Chargement en cours...
Extended Adjuvant Chemotherapy in Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) represents a heterogeneous breast cancer subtype with a poor prognosis. The optimal adjuvant chemotherapy regimen is still unknown. Although numerous large randomized trials have established the benefit of adjuvant anthracyclines and/or taxanes in TNBC, there is...
Enregistré dans:
| Publié dans: | Breast Care (Basel) |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
S. Karger GmbH
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5527164/ https://ncbi.nlm.nih.gov/pubmed/28785182 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000478087 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|